表紙
市場調査レポート

ドイツのヘルスケア、規制、医療費償還制度の状況

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany

発行 GlobalData 商品コード 275367
出版日 ページ情報 英文 299 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
ドイツのヘルスケア、規制、医療費償還制度の状況 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany
出版日: 2015年02月18日 ページ情報: 英文 299 Pages
概要

当レポートでは、ドイツのヘルスケア、規制、医療費償還制度の状況について調査分析し、医薬品・医療機器市場の概要、主要企業のプロファイルとSWOT分析、国の医療費償還制度・規制情勢、政治・経済環境について検証し、市場機会と課題も含めて、概略以下の構成でお届けいたします。

第1章 目次

第2章 イントロダクション

第3章 医薬品・医療機器市場の概要

  • 医薬品市場
  • 供給チャネル
  • 市場セグメント
  • 主な疾病分野
  • 主要企業
  • 医療機器市場

第4章 市場参入

  • 医療費償還・保険料払込者の状況
  • 規制の状況

第5章 国の分析

  • 政策環境
  • 経済情勢
  • 経済指標
  • 人口統計
  • 医療インフラ
  • 医療費
  • 産業団体
  • 見本市

第6章 機会と課題

  • 機会
  • 課題

第7章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC0079CHR

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Germany. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

Germany's increasingly elderly population and its associated disease burden are key drivers of its pharmaceutical market. In 2013, the elderly accounted for 27.1% of the total population, expected to increase at Compound Annual Growth Rate (CAGR) of 1.2% to 29.5% in 2020.

In 2008, healthcare expenditure as percentage of Gross Domestic Product (GDP) amounted to 10.7%, which increased to an estimated 11.5% in 2013. In 2011, the government initiated a new plan - Arzneimittelmarkt-Neuordnungsgesetz (AMNOG) - to curb healthcare expenditure.

The pharmaceuticals market was worth $54.7 billion in 2008 and is projected to have reached a value of approximately $65 billion by 2020 at a CAGR of 1.4%. The German medical device market was valued at $18.9 billion in 2008 and is projected to grow at a CAGR of 5.1% to reach $34.4 billion in 2020. These positive growth trends can be primarily attributed to -

  • The rising prevalence of chronic disease
  • Universal health coverage
  • Well established and centralized regulatory procedure

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Germany, and includes -

  • An overview of the pharmaceuticals and medical device markets, consisting of market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market - Novartis, Pfizer, Teva Pharmaceutical, Sanofi and Roche - and profiles and SWOT analyses of the major players in the medical device market - Medtronic, Siemens Healthcare, F. Hoffmann-La Roche, Philips Healthcare and GE Abbott Laboratories
  • Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by enabling you to -

  • Develop business strategies by understanding the trends shaping and driving Germany's healthcare market
  • Drive revenue by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Germany's healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
  • Identify, understand, and capitalize on the opportunities and challenges in Germany's healthcare market

Table of Contents

1 Table of Contents

1 Table of Contents 6

  • 1.1 List of Tables 9
  • 1.2 List of Figures 15

2 Introduction 20

  • 2.1 GlobalData Report Guidance 20

3 Overview of Pharmaceutical and Medical Device Market 21

  • 3.1 Pharmaceutical Market 21
    • 3.1.1 Market Overview 21
    • 3.1.2 Pharmaceutical Exports and Imports 24
    • 3.1.3 Supply Channels 25
    • 3.1.4 Market Segments 28
    • 3.1.5 Major Therapeutic Areas 34
    • 3.1.6 Major Players 38
  • 3.2 Medical Device Market 80
    • 3.2.1 Market Overview 80
    • 3.2.2 Overview of Top Five Segments 83
    • 3.2.3 Diagnostics Market 97
    • 3.2.4 Major Players 98
  • 3.3 Market Drivers and Barriers 134
    • 3.3.1 Drivers 134
    • 3.3.2 Barriers 136

4 Market Access 139

  • 4.1 Reimbursement and Payer Landscape 139
    • 4.1.1 Overview of Healthcare system 139
    • 4.1.2 Reimbursement Process 140
    • 4.1.3 Overview of Insurance Providers 145
    • 4.1.4 Patient Share in Healthcare Spending 149
    • 4.1.5 Price Trends in the Healthcare Sector 151
    • 4.1.6 Pricing Policies 153
  • 4.2 Regulatory Landscape 158
    • 4.2.1 Overview of Regulatory Agencies 158
    • 4.2.2 Market Authorization Procedure for Pharmaceutical Products 159
    • 4.2.3 New Medical Device Approval Process 169
    • 4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 174
    • 4.2.5 Exports and Imports 176
    • 4.2.6 Intellectual Property Rights 176
    • 4.2.7 Clinical Trial Regulations 182
    • 4.2.8 Pharmaceutical Advertising Regulations 185
    • 4.2.9 Pharmacy Regulations 186
    • 4.2.10 Labeling and Packaging Regulations 186

5 Country Analysis 189

  • 5.1 Political Environment 189
    • 5.1.1 Political Structure 189
    • 5.1.2 Analysis of Current Political Environment 191
    • 5.1.3 Healthcare Policy Initiatives 193
  • 5.2 Economic Landscape 196
  • 5.3 Economic Indicators 199
    • 5.3.1 Gross Domestic Product 199
    • 5.3.2 Gross National Income 203
    • 5.3.3 Inflation 205
    • 5.3.4 Currency Exchange Rate 208
    • 5.3.5 Foreign Direct Investment 209
    • 5.3.6 Foreign Exchange Reserves 211
    • 5.3.7 Trade Balance 212
    • 5.3.8 Government Structural Balance 214
    • 5.3.9 General Government Net Debt 216
    • 5.3.10 Major Industries 218
  • 5.4 Demographics 219
    • 5.4.1 Population 219
    • 5.4.2 Education and Literacy 237
    • 5.4.3 Employment 239
    • 5.4.4 Disease Burden 241
  • 5.5 Healthcare Infrastructure 244
    • 5.5.1 Healthcare Facilities 244
    • 5.5.2 Healthcare Parameters 248
    • 5.5.3 Environmental Health 252
    • 5.5.4 Healthcare Personnel 255
  • 5.6 Healthcare Expenditure 261
    • 5.6.1 Overview 261
    • 5.6.2 Major Components of Healthcare Spending 263
    • 5.6.3 Public and Private Sector Share 264
    • 5.6.4 Spending in Pharmaceutical Research and Development 265
  • 5.7 Trade Associations 266
    • 5.7.1 The Association of Research-based Pharmaceutical Companies 266
    • 5.7.2 The Federation of Pharmaceutical Manufacture 266
    • 5.7.3 The Federation of Pharmaceutical Industry 267
  • 5.8 Trade Fairs 268

6 Opportunities and Challenges 269

  • 6.1 Opportunities 269
  • 6.2 Challenges 269

7 Appendix 271

  • 7.1 Abbreviations 271
  • 7.2 Bibliography 277
  • 7.3 Research Methodology 296
    • 7.3.1 Coverage 296
    • 7.3.2 Secondary Research 297
    • 7.3.3 Forecasts 297
    • 7.3.4 Expert Panel 297
  • 7.4 Disclaimer 298

List of Tables

1.1 List of Tables

  • Table 1: Pharmaceutical Market, Germany, Revenue ($bn), 2008-2013 22
  • Table 2: Pharmaceutical Market, Germany, Revenue Forecast ($bn), 2014-2020 23
  • Table 3: Pharmaceutical Market, Germany, Exports and Imports ($bn), 2008-2013 24
  • Table 4: Pharmaceutical Market, Germany, Wholesale Mark-up for Proprietary Medicinal Products, 2014 27
  • Table 5: Pharmaceutical Market, Germany, Pharmacy Mark-up for Proprietary Medicinal Products, 2014 28
  • Table 6: Pharmaceutical Market, Germany, Generic Pharmaceutical Market Share (%), 2008-2013 29
  • Table 7: Pharmaceutical Market, Germany Drugs Going Off-patent, Global, 2014-2015 30
  • Table 8: Pharmaceutical Market, Germany, Biological Drugs in Pipeline, 2008-2013 31
  • Table 9: Pharmaceutical Market, Germany, OTC Drug Market Revenue ($bn), 2008-2013 32
  • Table 10: Pharmaceutical Market, Germany, Major OTC Drug Classes, Revenue and Share, 2013 33
  • Table 11: Pharmaceutical Market, Germany, Major Disease Areas, Total Cost of Illness ($bn), 2008 35
  • Table 12: Pharmaceutical Market, Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 39
  • Table 13: Pharmaceutical Market, Novartis, Global, Planned Filings, 2014-2018 40
  • Table 14: Pharmaceutical Market, Pfizer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 50
  • Table 15: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2014 51
  • Table 16: Pharmaceutical Market, Teva, Global Revenue of Major Products, 2013 59
  • Table 17: Pharmaceutical Market, Teva, Late-Stage Pipeline, 2013 59
  • Table 18: Pharmaceutical Market, Teva, Global, Major Products, 2013 61
  • Table 19: Pharmaceutical Market, Sanofi, Global, Major Products, 2013 66
  • Table 20: Pharmaceutical Market, Sanofi, Global, Late-stage Pipeline, 2014 67
  • Table 21: Pharmaceutical Market, F. Hoffmann-La Roche, Global, Major Products, Revenue ($m) and Annual Growth (%), 2013 72
  • Table 22: Pharmaceutical Market, F. Hoffmann-La Roche, Global, Late-stage Pipeline, 2013 73
  • Table 23: Medical Device Market, Germany, Revenue ($bn), 2008-2013 81
  • Table 24: Medical Device Market, Germany, Revenue Forecast ($bn), 2014-2020 82
  • Table 25: Medical Device Market, Germany, Revenue by Segment, 2013 83
  • Table 26: Medical Device Market, Germany, Cardiovascular Device Market ($m), 2008-2013 85
  • Table 27: Medical Device Market, Germany, Cardiovascular Device Market, Sales Trend for Major Players, 2012 86
  • Table 28: Medical Device Market, Germany, IVD Market ($m), 2008-2013 88
  • Table 29: Medical Device Market, Germany, IVD Market, Sales Trend for Major Players, 2012 89
  • Table 30: Medical Device Market, Germany, Orthopedic Device Market ($m), 2008-2013 90
  • Table 31: Medical Device Market, Germany, Orthopedic Device Market, Sales Trend for Major Players, 2012 91
  • Table 32: Medical Device Market, Germany, Wound Care Management Market ($m), 2008-2013 93
  • Table 33: Medical Device Market, Germany, Wound Care Management Market, Sales Trend for Major Players ($m), 2012 94
  • Table 34: Medical Device Market, Germany, Hospital Supplies Market ($m), 2008-2013 95
  • Table 35: Medical Device Market, Germany, Hospital Supplies Market, Sales Trend for Major Players ($m), 2012 96
  • Table 36: Medical Device Market, Germany, Diagnostics Market, Revenue ($bn), 2008-2013 97
  • Table 37: Medical Device Market, Germany, Diagnostic Market Revenue, Forecast ($bn), 2014-2020 98
  • Table 38: Medical Device Market, Germany, Major Medical Device Companies, Revenue, 2012 99
  • Table 39: Medical Device Market, Medtronic, Global, Major Products, 2013 101
  • Table 40: Medical Device Market, F. Hoffmann-La Roche, Global, Major Products, 2014 115
  • Table 41: Medical Device Market, Philips Healthcare, Global, Major Products, 2013 121
  • Table 42: Medical Device Market, Abbott, Global, Major Products, 2013 127
  • Table 43: Medical Device Market, Abbott, Global, Late-Stage Pipeline, 2014 127
  • Table 44: Market Access, Germany, Reimbursement Rates by Age, 2014 144
  • Table 45: Market Access, Germany, Number of SHI Providers, 2008-2013 146
  • Table 46: Healthcare Spending, Germany, Out-of-Pocket Expenditure (%), 2008-2013 150
  • Table 47: Healthcare Spending, Germany, Out-of-Pocket Expenditure (%), 2008-2013 151
  • Table 48: Market Access, Germany, Prescription Drug Prices, Annual Change (%), 2008-2013 152
  • Table 49: Market Access, Germany, Healthcare Price Index, Annual Change (%), 2008-2013 153
  • Table 50: Market Access, Germany, Early Assessment of Drugs, 2013 157
  • Table 51: Market Access, Germany, Patent Application Fees, 2014 177
  • Table 52: Market Access, Germany, Trademark Registration Fees, 2014 179
  • Table 53: Market Access, Germany, Voluntary Harmonization Procedure, 2014 184
  • Table 54: Economic Indicators, Germany, Gross Domestic Product per Capita ($), 2008-2013 200
  • Table 55: Economic Indicators, Germany, Gross Domestic Product per Capita ($) Forecast, 2014-2020 201
  • Table 56: Economic Indicators, Germany, Gross Domestic Product Annual Growth (%), 2008-2013 202
  • Table 57: Economic Indicators, Germany, Gross Domestic Product Annual Growth Forecast (%), 2014-2020 203
  • Table 58: Economic Indicators, Germany, Gross National Income per Capita ($), 2008-2013 204
  • Table 59: Economic Indicators, Germany, Average Consumer Price Index, 2008-2013 206
  • Table 60: Economic Indicators, Germany, Average Consumer Price Index Forecast, 2014-2020 206
  • Table 61: Economic Indicators, Germany, Average Consumer Price Annual Change (%), 2008-2013 207
  • Table 62: Economic Indicators, Germany, Currency Exchange Rate (€/$), 2008-2013 209
  • Table 63: Economic Indicators, Germany, Foreign Direct Investment ($bn), 2008-2013 210
  • Table 64: Economic Indicators, Germany, Foreign Exchange Reserves ($bn), 2008-2013 211
  • Table 65: Economic Indicators, Germany, Imports of Goods and Services ($bn), 2008-2013 213
  • Table 66: Economic Indicators, Germany, Exports of Goods and Services ($bn), 2008-2013 214
  • Table 67: Economic Indicators, Germany, Government Structural Balance ($bn), 2008-2013 215
  • Table 68: Economic Indicators, Germany, General Government Net Debt ($bn), 2008-2013 216
  • Table 69: Economic Indicators, Germany, General Government Net Debt ($bn) Forecast, 2014-2020 217
  • Table 70: Economic Indicators, Germany, Major Industries, Gross Value Added ($bn), 2013 219
  • Table 71: Demographics, Germany, Population (million), 2008-2013 220
  • Table 72: Demographics, Germany, Population (million) Forecast, 2014-2020 221
  • Table 73: Demographics, Germany, Population, Urban and Rural Population Share (%), 2008-2013 222
  • Table 74: Demographics, Germany, Population Distribution by Age Group (%), 2008-2013 224
  • Table 75: Demographics, Germany, Population Distribution by Age Group Forecast (%), 2014-2020 225
  • Table 76: Demographics, Germany, Births (per 1,000 Population), 2008-2013 226
  • Table 77: Demographics, Germany, Mortality (per 1,000 Population), 2008-2013 227
  • Table 78: Demographics, Germany, Major Causes of Mortality ('000), 2013 229
  • Table 79: Demographics, Germany, Children ≤5 Years, Mortality Rate (per 1,000 Live Births), 2008-2013 230
  • Table 80: Demographics, Germany, Major Causes of Male Mortality ('000), 2013 231
  • Table 81: Demographics, Germany, Major Causes of Female Mortality ('000), 2013 233
  • Table 82: Demographics, Germany, Immunization Rate (%), 2008-2013 234
  • Table 83: Demographics, Germany, Gender Ratio (Male/Female), 2008-2013 235
  • Table 84: Demographics, Germany, Life Expectancy at Birth (Years), 2006-2011 236
  • Table 85: Demographics, Germany, Highest Level of General Education Completed, Share (%), 2013 238
  • Table 86: Demographics, Germany, Vocational Qualification, Share (%), 2013 239
  • Table 87: Demographics, Germany, Unemployment Rate (%), 2008-2013 240
  • Table 88: Demographics, Germany, Most Frequently Diagnosed Diseases, Patients ('000), 2012 242
  • Table 89: Demographics, Germany, Major Diseases, DALY (Per 100,000 Population), 2004 243
  • Table 90: Healthcare Infrastructure, Germany, Hospitals, 2008-2013 245
  • Table 91: Healthcare Infrastructure, Germany, Acute Care Hospitals (per 100,000 Population), 2008-2013 246
  • Table 92: Healthcare Infrastructure, Germany, Diagnostic Equipment# (Units per Million Population), 2008-2013 247
  • Table 93: Healthcare Infrastructure, Germany, Hospital Beds (per 1,000 Population), 2008-2013 249
  • Table 94: Healthcare Infrastructure, Germany, Acute Care Hospitals Beds (per 1,000 Population), 2008-2013 250
  • Table 95: Healthcare Infrastructure, Germany, Psychiatric Hospital Beds (per 1,000 Population), 2008-2013 251
  • Table 96: Healthcare Infrastructure, Germany, PM10 (µg/m3), 2008-2013 253
  • Table 97: Healthcare Infrastructure, Germany, CO2 (in million tons), 2008-2013 254
  • Table 98: Healthcare Infrastructure, Germany, Full-Time Healthcare Personnel ('000), 2008-2013 256
  • Table 99: Healthcare Infrastructure, Germany, Physicians (per 1,000 Population), 2008-2013 258
  • Table 100: Healthcare Infrastructure, Germany, Dentists (per 1000 population), 2008-2013 259
  • Table 101: Healthcare Infrastructure, Germany, Pharmacist (Per 1,000 Population), 2008-2013 260
  • Table 102: Healthcare Infrastructure, Germany, Nurses (per 1,000 Population), 2008-2013 261
  • Table 103: Healthcare Infrastructure, Germany, Healthcare Expenditure (% of GDP), 2008-2013 262
  • Table 104: Healthcare Infrastructure, Germany, Healthcare Expenditure, Major Component Share (%), 2012 263
  • Table 105: Healthcare Infrastructure, Germany, Healthcare Expenditure, Public-Private Share (%), 2008-2013 264
  • Table 106: Healthcare Infrastructure, Germany, Research and Development Expenditure ($bn), 2008-2013 265
  • Table 107: Major Healthcare Trade Fairs, Germany, 2015 268

List of Figures

1.2 List of Figures

  • Figure 1: Pharmaceutical Market, Germany, Revenue ($bn), 2008-2013 22
  • Figure 2: Pharmaceutical Market, Germany, Revenue Forecast ($bn), 2014-2020 23
  • Figure 3: Pharmaceutical Market, Germany, Exports and Imports ($bn), 2008-2013 24
  • Figure 4: Pharmaceutical Market, Germany, Supply Channel, 2010 26
  • Figure 5: Pharmaceutical Market, Germany, Generic Pharmaceutical Market Share (%), 2008-2013 29
  • Figure 6: Pharmaceutical Market, Germany, Biological Drugs in Pipeline, 2008-2013 31
  • Figure 7: Pharmaceutical Market, Germany, OTC Drug Market Revenue ($bn), 2008-2013 32
  • Figure 8: Pharmaceutical Market, Germany, Major OTC Drug Classes, Revenue ($m), 2013 33
  • Figure 9: Pharmaceutical Market, Germany, Major Disease Areas, Total Cost of Illness ($bn), 2008 34
  • Figure 10: Medical Device Market, Germany, Revenue ($bn), 2008-2013 81
  • Figure 11: Medical Device Market, Germany, Revenue Forecast ($bn), 2014-2020 82
  • Figure 12: Medical Device Market, Germany, Revenue by Segment ($bn), 2013 83
  • Figure 13: Medical Device Market, Germany, Cardiovascular Device Market ($m), 2008-2013 85
  • Figure 14: Medical Device Market, Germany, Cardiovascular Device Market, Sales Trend for Major Players, 2008-2012 86
  • Figure 15: Medical Device Market, Germany, IVD Market ($m), 2008-2013 87
  • Figure 16: Medical Device Market, Germany, IVD Market, Sales Trend for Major Players, 2008-2012 88
  • Figure 17: Medical Device Market, Germany, Orthopedic Device Market ($m), 2008-2013 90
  • Figure 18: Medical Device Market, Germany, Orthopedic Device Market, Sales Trend for Major Players, 2008-2012 91
  • Figure 19: Medical Device Market, Germany, Wound Care Management Market ($m), 2008-2013 92
  • Figure 20: Medical Device Market, Germany, Wound Care Management Market, Sales Trend for Major Players ($m), 2008-2012 93
  • Figure 21: Medical Device Market, Germany, Hospital Supplies Market ($m), 2008-2013 95
  • Figure 22: Medical Device Market, Germany, Hospital Supplies Market, Sales Trend for Major Players ($m), 2008-2012 96
  • Figure 23: Medical Device Market, Germany, Diagnostics Market, Revenue ($bn), 2008-2013 97
  • Figure 24: Medical Device Market, Germany, Diagnostic Market Revenue, Forecast ($bn), 2014-2020 98
  • Figure 25: Medical Device Market, Germany, Major Medical Device Companies, Revenue ($m), 2012 99
  • Figure 26: Healthcare Market, Germany, Drivers and Barriers, 2014 138
  • Figure 27: Market Access, Germany, Roles of Regulatory Bodies, 2014 142
  • Figure 28: Market Access, Germany, Reimbursement Process, 2014 143
  • Figure 29: Market Access, Germany, Number of SHI Providers, 2008-2013 146
  • Figure 30: Healthcare Spending, Germany, Out-of-Pocket Expenditure (%), 2008-2013 149
  • Figure 31: Market Access, Germany, Prescription Drug Prices, Annual Change (%), 2008-2013 152
  • Figure 32: Market Access, Germany, Healthcare Price Index, Annual Change (%), 2008-2013 153
  • Figure 33: Market Access, Germany, AMNOG Reimbursement Process for Drugs, 2014 157
  • Figure 34: Market Access, Germany, Organizational Structure of BfArM, 2014 158
  • Figure 35: Market Access, Germany, Organizational Structure of PEI, 2014 159
  • Figure 36: Market Access, EU, Centralized Procedure for Market Authorization, Pre-Submission, 2012 162
  • Figure 37: Market Access, EU, Centralized Procedure, Market Authorization, Pre-Opinion Phase, 2012 163
  • Figure 38: Market Access, EU, Centralized Procedure, Market Authorization, Post-Opinion Phase, 2012 164
  • Figure 39: Market Access, EU, Decentralized Procedure, Market Authorization, 2012 166
  • Figure 40: Market Access, EU, Mutual Recognition Procedure, Market Authorization, 2012 167
  • Figure 41: Market Access, EU, Conformity Assessment of Class I Medical Devices, 2014 171
  • Figure 42: Market Access, EU, Conformity Assessment of Class IIa Medical Devices, 2014 172
  • Figure 43: Market Access, EU, Conformity Assessment of Class IIb Medical Devices, 2014 173
  • Figure 44: Market Access, EU, Conformity Assessment of Class III Medical Devices, 2014 174
  • Figure 45: Market Access, Germany, Patent Approval Process, 2014 178
  • Figure 46: Market Access, Germany, Trademark Approval Process, 2014 181
  • Figure 47: Economic Indicators, Germany, Gross Domestic Product Per Capita ($), 2008-2013 200
  • Figure 48: Economic Indicators, Germany, Gross Domestic Product per Capita ($) Forecast, 2014-2020 201
  • Figure 49: Economic Indicators, Germany, Gross Domestic Product Annual Growth (%), 2008-2013 202
  • Figure 50: Economic Indicators, Germany, Gross Domestic Product Annual Growth Forecast (%), 2014-2020 203
  • Figure 51: Economic Indicators, Germany, Gross National Income per Capita ($), 2008-2013 204
  • Figure 52: Economic Indicators, Germany, Average Consumer Price Index, 2008-2013 205
  • Figure 53: Economic Indicators, Germany, Average Consumer Price Index Forecast, 2014-2020 206
  • Figure 54: Economic Indicators, Germany, Average Consumer Price Annual Change (%), 2008-2013 207
  • Figure 55: Economic Indicators, Germany, Currency Exchange Rate (€/$), 2008-2013 209
  • Figure 56: Economic Indicators, Germany, Foreign Direct Investment ($bn), 2008-2013 210
  • Figure 57: Economic Indicators, Germany, Forex Reserve ($bn), 2008-2013 211
  • Figure 58: Economic Indicators, Germany, Imports of Goods and Services ($bn), 2008-2013 212
  • Figure 59: Economic Indicators, Germany, Exports of Goods and Services ($bn), 2008-2013 214
  • Figure 60: Economic Indicators, Germany, Government Structural Balance ($bn), 2008-2013 215
  • Figure 61: Economic Indicators, Germany, General Government Net Debt ($bn), 2008-2013 216
  • Figure 62: Economic Indicators, Germany, General Government Net Debt ($bn) Forecast, 2014-2020 217
  • Figure 63: Economic Indicators, Germany, Major Industries, Gross Value Added ($bn), 2013 218
  • Figure 64: Demographics, Germany, Population (million), 2008-2013 220
  • Figure 65: Demographics, Germany, Population (million) Forecast, 2014-2020 221
  • Figure 66: Demographics, Germany, Urban-Rural Population Share (%), 2008-2013 222
  • Figure 67: Demographics, Germany, Population Distribution by Age Group (%), 2008-2013 223
  • Figure 68: Demographics, Germany, Population Distribution by Age Group (%) Forecast, 2014-2020 224
  • Figure 69: Demographics, Germany, Births (per 1,000 Population), 2008-2013 226
  • Figure 70: Demographics, Germany, Mortality (per 1,000 Population), 2008-2013 227
  • Figure 71: Demographics, Germany, Major Causes of Mortality ('000), 2013 228
  • Figure 72: Demographics, Germany, Children ≤5 Years, Mortality Rate (per 1,000 Live Births), 2008-2013 230
  • Figure 73: Demographics, Germany, Major Causes of Male Mortality ('000), 2013 231
  • Figure 74: Demographics, Germany, Major Causes of Female Mortality ('000), 2013 232
  • Figure 75: Demographics, Germany, Immunization Rate (%), 2008-2013 234
  • Figure 76: Demographics, Germany, Gender Ratio (Male/Female), 2008-2013 235
  • Figure 77: Demographics, Germany, Life Expectancy at Birth (Years), 2006-2011 236
  • Figure 78: Demographics, Germany, Highest Level of General Education Completed, Share (%), 2013 238
  • Figure 79: Demographics, Germany, Vocational Qualification, Share (%), 2013 239
  • Figure 80: Demographics, Germany, Unemployment Rate (%), 2008-2013 240
  • Figure 81: Demographics, Germany, Most Frequently Diagnosed Diseases ('000), 2012 241
  • Figure 82: Demographics, Germany, Major Diseases, DALY (Per 100,000 Population), 2004 243
  • Figure 83: Healthcare Infrastructure, Germany, Hospitals, 2008-2013 245
  • Figure 84: Healthcare Infrastructure, Germany, Acute Care Hospitals (per 100,000 Population), 2008-2013 246
  • Figure 85: Healthcare Infrastructure, Germany, Diagnostic Equipment# (Units per Million Population), 2008-2013 247
  • Figure 86: Healthcare Infrastructure, Germany, Hospital Beds (per 1,000 Population), 2008-2013 248
  • Figure 87: Healthcare Infrastructure, Germany, Acute Care Hospital Beds (per 1,000 Population), 2008-2013 250
  • Figure 88: Healthcare Infrastructure, Germany, Psychiatric Hospital Beds (per 1,000 Population), 2008-2013 251
  • Figure 89: Healthcare Infrastructure, Germany, PM10 (µg/m3), 2008-2013 253
  • Figure 90: Healthcare Infrastructure, Germany, CO2 (in Million Tons), 2008-2013 254
  • Figure 91: Healthcare Infrastructure, Germany, Full-Time Healthcare Personnel ('000), 2008-2013 256
  • Figure 92: Healthcare Infrastructure, Germany, Physicians (per 1,000 Population), 2008-2013 257
  • Figure 93: Healthcare Infrastructure, Germany, Dentists (per 1,000 Population), 2008-2013 258
  • Figure 94: Healthcare Infrastructure, Germany, Pharmacist s (per 1,000 Population), 2008-2013 259
  • Figure 95: Healthcare Infrastructure, Germany, Nurses (per 1,000 Population), 2008-2013 260
  • Figure 96: Healthcare Infrastructure, Germany, Healthcare Expenditure (% of GDP), 2008-2013 262
  • Figure 97: Healthcare Infrastructure, Germany, Healthcare Expenditure, Major Component Share (%), 2012 263
  • Figure 98: Healthcare Infrastructure, Germany, Healthcare Expenditure, Public-Private Share (%), 2008-2013 264
  • Figure 99: Healthcare Infrastructure, Germany, Research and Development Expenditure ($bn), 2008-2013 265
  • Figure 100: Healthcare Market, Germany, Opportunities and Challenges, 2014 270
Back to Top